Allo graft rejection remains the main obstacle of transplantation medicine.

移植排斥仍然是器管移植领域中急待解决的前沿课题。

Acute and chronic graft rejection are the major factors leading to graft non-function.

器官移植术后急、慢性排斥反应是导致移植物功能丧失的重要原因之一。

Acute and chronic graft rejection are the major factors leading to graft non - function.

器官移植术后急、慢性排斥反应是导致移植物功能丧失的重要原因之一.

It is a new tendency to use gene chip to research graft rejection at gene level.

通过基因芯片技术从基因水平上研究移植排斥相关问题是目前的新趋势.

The data of tear film break-up time ofthe operative eye was 0 with corneal graft rejection;

当发生排斥发应时，术眼泪膜破裂时间为0；

Pancreas graft rejection or dysfunction was not observed with the above immunosuppression modification.

在免疫抑制调整期间并未发现胰腺排斥或功能不全。

Thus, an optimal approach would involve an islet transplantation protocol that would prevent graft rejection without the need for potentially dangerous long-term and nonspecific immune suppression.

因此一个理想的疗法应该具备以下几点：它是一个能防止潜在长期危险和排异反应并无需非特异型免疫抑制疗法的胰岛移植方案。